[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368083-105":59,"doc-detail-368083-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluation-of-germline-pathogenic-variant-of-tp53-gene-in-an-iranian-pedigree-with-familial-sarcoma-a-case-report","Evaluation of Germline Pathogenic Variant of TP53 Gene in an Iranian Pedigree with Familial Sarcoma - A Case Report","","Sarcomas are rare mesenchymal cancers with heterogeneous genetic and histological features, and recognizing inherited genetic contributors can improve diagnosis and targeted treatment strategies. This case report describes an Iranian pedigree with familial sarcoma in which the proband, a young woman, has osteosarcoma of the upper jawbone. Whole-exome sequencing identified a pathogenic TP53 germline variant, and co-segregation analysis supported its presence among affected relatives, consistent with familial Li-Fraumeni syndrome. The findings suggest that TP53 germline mutation is important in initiating and spreading sarcoma within this family.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-of-germline-pathogenic-variant-of-tp53-gene-in-an-iranian-pedigree-with-familial-sarcoma-a-case-report/368083/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-of-germline-pathogenic-variant-of-tp53-gene-in-an-iranian-pedigree-with-familial-sarcoma-a-case-report/368083.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What case does this report focus on, and what cancer does the proband have?","Question",{"text":112,"@type":113},"The report describes a familial sarcoma pedigree in an Iranian family, where the proband is a young woman with osteosarcoma involving the upper jawbone.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genetic method was used to identify the variant, and what gene was implicated?",{"text":117,"@type":113},"Whole-exome sequencing was used, and it recognized a pathogenic germline variant in the TP53 gene.",{"name":119,"@type":110,"acceptedAnswer":120},"How did additional investigation support the inheritance pattern in the family?",{"text":121,"@type":113},"Co-segregation analysis assessed affected and unaffected family members and supported the presence of the mutation in some affected relatives, consistent with familial Li-Fraumeni syndrome.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368083,1790174901,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":129,"read_time":143,"preview_page_count":19,"preview_urls":144},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","| Case Report |\n| --- |\n|  |\n\nEvaluation of Germline Pathogenic Variant of TP53 Gene in an Iranian Pedigree with Familial Sarcoma: A Case Report  \nZahra Ebrahimi1, Mehrdad Zeinalian1,2, Mahdieh Nejadtaghi3, Mohammad A. Tabatabaeifar1,4  \n1Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran, 2Ala Cancer Prevention and Control Center, Isfahan, Iran, 3Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran, 4Pediatric Inherited Disease Research Center, Research Institute for Primordial Prevention of Non‑communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran  \nAbstract  \nSarcomas are rare cancers that occur in mesenchymal tissues. The acknowledgment of genetic factors in these heterogeneous neoplasms could cause progress in diagnoses and targeted therapy. Sarcomas have two main categories: soft tissue and bone sarcoma. These cancers have been associated with some hereditary cancer syndrome like Li‑Fraumeni Syndrome. In this research, we present a pedigree with familial sarcoma. Our proband is a young woman with osteosarcoma involving her upper jawbone. The patient had a family history of many cases of sarcoma, brain tumors, especially osteosarcoma; also, we considered the association of cancer predisposing syndrome and high rate of sarcomas in this family. By means of whole‑exome sequencing, one pathogenic variant ofTP53 gene was recognized. Additional investigation like co‑segregation analysis assessed the existence of this mutation in some of affected and unaffected family members and showed that probably this family is a case of familial Li‑Fraumeni syndrome. This finding suggested that germline mutation of TP53 gene play an important role in initiating and spreading sarcoma in this family with Li‑Fraumeni syndrome.  \nKeywords: Co‑segregation analysis, germline mutation, Li‑Fraumeni syndrome, sarcoma, TP53 gene, whole‑exome sequencing  \nAddress for correspondence: Dr. Mehrdad Zeinalian, Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81746‑73461, Iran.  \nE‑mail: [zeinalianmehrdad@gmail.com](zeinalianmehrdad@gmail.com)  \nSubmitted: 18‑Feb‑2024; Revised: 06‑Oct‑2025; Accepted: 07‑Oct‑2025; Published: 30‑Dec‑2025  \nIntroductIon  \nSarcomas encompass a diverse group of rare mesenchymal neoplasms arising in connective tissue that have a poor prognosis . [1] These aggressive tumors account for less than 1% of all new cancer diagnoses . [2] Sarcomas are heterogeneous cancers with two main subtypes: soft tissue sarcoma (STS) and bone sarcoma. STS has many subtypes, including liposarcoma (LPS), leiomyosarcoma (LMS), and gastrointestinal stromal tumors (GIST) . LPS accounts for 20–25% of STS cases and is the most common type in this subgroup. Bone sarcomas account for 0.2% of all newly diagnosed cancers, with osteosarcoma (OS) being the most common type in this category. OS is frequently observed in adolescents and the younger population.[3]  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code:\u003Cbr>| Website:\u003Cbr>[https://journals.lww.com/ADBM](https://journals.lww.com/ADBM) |\n|  | DOI:\u003Cbr>10.4103/abr.abr_73_24 |\n\nThe management of sarcomas is challenging because these diverse tumors have broad heterogeneity in genetic components, signaling pathways, and histological subtypes.[4] Gene mutations are common among sarcomas and are sometimes known to be crucial factors in sarcomagenesis. Therefore, insight into these gene mutations provides an improvement in identifying the origins of sarcoma development and managing therapeutic actions.[5]  \nGenerally, the total rate of somatic mutations is low, although mutations inNRAS, KRAS, and PIK3CA have been reported.[6]  \nBasic studies have shown that several pathways are activated in special types of sarcomas. Some of these regulators and oncogenic pathways consist of Wnt, mTOR, Notch","cbCaibU7GpOHEwZo","https://ap.wps.com/l/cbCaibU7GpOHEwZo","pdf",1180109,"English","# Abstract\n# Introduction\n## Sarcoma overview and prognosis\n## Genetic mechanisms and common pathways\n## Hereditary cancer syndromes and TP53 role","[{\"question\":\"What case does this report focus on, and what cancer does the proband have?\",\"answer\":\"The report describes a familial sarcoma pedigree in an Iranian family, where the proband is a young woman with osteosarcoma involving the upper jawbone.\"},{\"question\":\"Which genetic method was used to identify the variant, and what gene was implicated?\",\"answer\":\"Whole-exome sequencing was used, and it recognized a pathogenic germline variant in the TP53 gene.\"},{\"question\":\"How did additional investigation support the inheritance pattern in the family?\",\"answer\":\"Co-segregation analysis assessed affected and unaffected family members and supported the presence of the mutation in some affected relatives, consistent with familial Li-Fraumeni syndrome.\"}]","Evaluation of Germline Pathogenic Variant of TP53 Gene in an Iranian Pedigree with Familial Sarcoma - A Case Report | PDF",13,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0be370ff8554ec2788ad28560e5b9e4.webp",983,1272,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea508d640ac6d1556356c3e1563810fb.webp",982,1270,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf536666e9e427b401875c437df18357.webp",981,1269,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75a15b4f54215a531b59119b96cb1366.webp",980,1268]